Skip to main content
Equibles
CYCN logo

CYCN

Cyclerion Therapeutics, Inc.
$3.48 +0.02 (+0.58%) At close · Jul 7
Market Cap
$15.07M
Shares
4,330,314

Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K, with the reported result and management tone at a glance.

Revenue & result across quarters

Revenue ($B) YoY up YoY down artefacts
LATEST ▼100% '23 Q1 23-05-12 ▲14.3% '22 Q4 23-03-22 ▼89.8% '22 Q2 22-08-09 ▲1046.8% '22 Q1 22-05-04 ▲300% '21 Q4 22-02-24 ▼13% '21 Q3 21-11-09 ▲300.5% '21 Q2 21-07-29 ▼93.9% '21 Q1 21-04-27 · '20 Q4 21-01-13 ▼54% '20 Q2 20-07-09 · '20 Q1 20-04-14
Earnings call
FY23 · Q1
2023-05-12
Cyclerion Therapeutics, Inc. Q1 FY2023 Earnings Call
Revenue
$
▼ 100% YoY
Diluted EPS
$-3.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-22
Cyclerion Therapeutics, Inc. Q4 FY2022 Earnings Call
Revenue
$608,000*
▲ 14.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-08-09
Cyclerion Therapeutics, Inc. Q2 FY2022 Earnings Call
Revenue
$306,000
▼ 89.8% YoY
Diluted EPS
$-6.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Cyclerion Therapeutics, Inc. Q1 FY2022 Earnings Call
Revenue
$711,000
▲ 1046.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Cyclerion Therapeutics, Inc. Q4 FY2021 Earnings Call
Revenue
$532,000*
▲ 300% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Cyclerion Therapeutics, Inc. Q3 FY2021 Earnings Call
Revenue
$348,000
▼ 13% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Cyclerion Therapeutics, Inc. Q2 FY2021 Earnings Call
Revenue
$3.00M
▲ 300.5% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-27
Cyclerion Therapeutics, Inc. Q1 FY2021 Earnings Call
Revenue
$62,000
▼ 93.9% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-13
Cyclerion Therapeutics, Inc. Q4 FY2020 Earnings Call
Revenue
$133,000*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2020-07-09
Cyclerion Therapeutics, Inc. Q2 FY2020 Earnings Call
Revenue
$749,000
▼ 54% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-14
Cyclerion Therapeutics, Inc. Q1 FY2020 Earnings Call
Revenue
$1.01M
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–11 of 11 earnings calls
Key facts CIK 1755237 CUSIP 23255M204 Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)